Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Platypus Technologies Receives Phase I SBIR for $200k

Platypus Technologies Receives Phase I SBIR for $200k

July 27, 2005

Platypus Technologies has received a Phase I Small Business Innovation Research (SBIR) grant for $200,000 from the National Cancer Institute. The grant is to develop a new liquid-crystal based technology for rapid quantification of protein activity, useful for cancer research.

Platypus Technologies was founded in 2000 to develop nanotechnology products for the physical and life sciences.

####

About Platypus Technologies:
Platypus Technologies, LLC develops, produces and markets nanotechnologies for the life sciences. We produce a variety of nano-structured surfaces for use in research and are also developing a range of products that derive from a proprietary platform technology using liquid crystals for the rapid detection of molecular interactions. This technology fuses recent advances in nano-scale science, materials science and molecular biology to provide advanced tools for proteomics, cell studies, environmental monitoring and in vitro diagnostics.

Currently, Platypus offers obliquely-deposited gold slides, gold-coated glass slides / mica / silicon wafers / coverslips, optically transparent polyurethane substrates with topography, Functionalization Kits and Contact Printing Kits.

For more information, please visit www.platypustech.com


Contact:
Minnie Gupta
Director of Marketing
237-1270, ext. 303
rgupta@platypustech.com

Copyright © Platypus Technologies

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Investments/IPO's/Splits

Daikin Industries becomes OCSiAl shareholder July 27th, 2021

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

Nanomedicine

High-tech 'paint' could spare patients repeated surgeries March 8th, 2024

Researchers develop artificial building blocks of life March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project